Literature DB >> 12207097

Incidence of infectious morbidity and mortality in dialysis patients.

R Vanholder1, W Van Biesen.   

Abstract

Infections remain among the major causes of disease, hospitalization and death in uremic patients, especially in those treated by dialysis. Several pathophysiologic factors enhance this infectious risk: (1) breakdown of protective barriers; (2) affinity of bacteria for foreign materials; (3) bioincompatibility; (4) uremic toxin retention; (5) deficiency and resistance to vitamin D; (6) carriership of germs, and (7) malnutrition. Twenty to 30% of dialysis patients develop infection, and 20-30% of these die from their infection. Sepsis is significantly more frequent, and mortality secondary to sepsis is 50 times higher than in the normal population. Bacteremia (prevalence 1 episode/100 patient-months) is mainly caused by Gram-positive species, especially in vascular access-related infection and infection of unknown origin. Among these Gram-positive germs, staphylococci play a predominant role. The most frequent and most morbid viral infections are associated with hepatitis. Whereas the incidence of hepatitis B decreases, hepatitis C has become the major variant. The incidence of tuberculosis has increased up to 15 times, and in the Western world it mainly affects patients who immigrated from endemic areas. Fungal infections are also frequent, especially in the setting of peritoneal dialysis. In conclusion, infections remain a frequent and morbid problem in dialysis patients. Preventive measures should be applied more vigorously. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12207097     DOI: 10.1159/000063556

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  12 in total

1.  Disease Activity and Adverse Events in Patients with ANCA-Associated Vasculitides Undergoing Long-Term Dialysis.

Authors:  Maëlis Kauffmann; Mickaël Bobot; Thomas Robert; Stéphane Burtey; Grégoire Couvrat-Desvergnes; Frédéric Lavainne; Xavier Puéchal; Benjamin Terrier; Thomas Quéméneur; Stanislas Faguer; Alexandre Karras; Philippe Brunet; Cécile Couchoud; Noémie Jourde-Chiche
Journal:  Clin J Am Soc Nephrol       Date:  2021-11       Impact factor: 8.237

2.  Causes of death in peritoneal dialysis patients with different kidney diseases and comorbidities: a retrospective clinical analysis in a Chinese center.

Authors:  Qianying Zhang; Hong Ren; Jingyuan Xie; Xiao Li; Xiaomin Huang; Nan Chen
Journal:  Int Urol Nephrol       Date:  2013-10-05       Impact factor: 2.370

Review 3.  Management of invasive candidiasis in critically ill patients.

Authors:  Stijn Blot; Koenraad Vandewoude
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Cytomegalovirus contributes partly to uraemia-associated premature immunological ageing of the T cell compartment.

Authors:  R W J Meijers; N H R Litjens; E A de Wit; A W Langerak; A van der Spek; C C Baan; W Weimar; M G H Betjes
Journal:  Clin Exp Immunol       Date:  2013-12       Impact factor: 4.330

Review 5.  Role of vitamin D in chronic kidney disease.

Authors:  Tejas V Patel; Ajay K Singh
Journal:  Semin Nephrol       Date:  2009-03       Impact factor: 5.299

6.  Infection-related hospitalizations over 30 years of follow-up in patients starting renal replacement therapy at pediatric age.

Authors:  Danilo Lofaro; Judith L Vogelzang; Karlijn J van Stralen; Kitty J Jager; Jaap W Groothoff
Journal:  Pediatr Nephrol       Date:  2016-02       Impact factor: 3.714

7.  Vitamin D's potential to reduce the risk of hospital-acquired infections.

Authors:  Dima A Youssef; Tamra Ranasinghe; William B Grant; Alan N Peiris
Journal:  Dermatoendocrinol       Date:  2012-04-01

8.  Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study.

Authors:  I-Kuan Wang; Cheng-Li Lin; Po-Chang Lin; Chih-Chia Liang; Yao-Lung Liu; Chiz-Tzung Chang; Tzung-Hai Yen; Donald E Morisky; Chiu-Ching Huang; Fung-Chang Sung
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

9.  Serum Alkaline Phosphatase Levels Predict Infection-Related Mortality and Hospitalization in Peritoneal Dialysis Patients.

Authors:  Seun Deuk Hwang; Su-Hyun Kim; Young Ok Kim; Dong Chan Jin; Ho Chul Song; Euy Jin Choi; Yong-Lim Kim; Yon-Su Kim; Shin-Wook Kang; Nam-Ho Kim; Chul Woo Yang; Yong Kyun Kim
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

Review 10.  Omics for Investigating Chitosan as an Antifungal and Gene Modulator.

Authors:  Federico Lopez-Moya; Luis V Lopez-Llorca
Journal:  J Fungi (Basel)       Date:  2016-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.